Company to host conference call and webcast
today at 11:00 a.m. Eastern time to
discuss the results
LONGMONT, Colo., Nov. 1, 2024
/PRNewswire/ -- S&W Seed Company (Nasdaq: SANW) today announced
financial results for the fiscal year ended June 30, 2024.
Financial Highlights
- Revenue for fiscal 2024 was $60.4
million, a 17.8% decrease compared to fiscal 2023. Double
Team™ sorghum revenue was $10.9
million in fiscal 2024 compared to $6.5 million in fiscal 2023.
- Gross profit margin for fiscal 2024 was 26.2%, an improvement
from 19.8% in fiscal 2023.
- Gross profit dollar for fiscal 2024 was $15.8 million, an improvement of $1.3 million from $14.5
million in fiscal 2023.
- GAAP net loss was ($30.1)
million, or ($13.21) per basic
and diluted share, for fiscal 2024 compared to GAAP net income of
$14.4 million, or $6.40 per basic share and $6.38 per diluted share, for fiscal 2023. A
$38.2 million gain was recognized in
fiscal 2023 related to the formation of Vision Bioenergy
Oilseeds LLC, or Vision Bioenergy, a biofuel production partnership
with Equilon Enterprises LLC (dba Shell Oil Products US, or
Shell).
- Adjusted EBITDA (see Table B) was ($8.5)
million for fiscal 2024 compared to ($9.3) million for fiscal 2023.
- Received $6.0 million payment
from Shell in February 2024 as
additional consideration related to the formation of
Vision Bioenergy in February
2023. Received $1.0 million
payment from Trigall Genetics S.A., or Trigall, in January 2024 as additional consideration related
to the sale of 80% interest in Trigall Australia Pty Ltd., or
Trigall Australia, a wheat development partnership, in December 2022. Received additional $0.4 million from Trigall in May 2024 for the sale of remaining 20% interest
in Trigall Australia and assets used in the partnership.
Management Discussion
"Since taking over as CEO in July
2023, my focus has been to define our business strategies to
optimize results centered around best-in-class operational
effectiveness of our broader sorghum technology program and forage
operations," commented S&W Seed Company's CEO, Mark Herrmann. "Within our Americas operations,
which is led by our proprietary, high-value sorghum Double Team
trait technology, we enacted a number of strategies to increase
adoption of Double Team while improving operational efficiencies.
This resulted in Double Team revenue increasing by 68.1% during
fiscal 2024, which was a lead driver in boosting our company-wide
gross margins increase of 640 basis points to 26.2% in fiscal 2024,
up from 19.8% in the previous year. On a dollar basis, gross profit
dollars increased to $15.8 million in
fiscal 2024 compared to $14.5 million
in the year ago period. Our commercial launch of Double Team has
gone exceedingly well, with expectations for the proprietary,
high-value sorghum trait technology to be planted on approximately
10% of all sorghum acres in the United
States in 2024. As total revenue in the future continues to
shift more towards our robust sorghum technology portfolio which
carries gross margins in excess of 60%, including product line
extensions and new technology offerings planned over the next year,
we expect to see operational improvement in support of our
near-term goal of profitability."
"While the Americas operations continue to improve and meet our
expectations, we have experienced challenges to our international
operations. As a reminder, in early 2023, we communicated that we
were working on the possibility of a strategic transaction
involving our international operations, headquartered in
Australia. Upon further evaluation
of the changes within our international commercial footprint, among
other factors, we announced that one of our subsidiaries, S&W
Australia, had entered Voluntary Administration, or VA, under
applicable Australian law effective July 24,
2024. This decision was made after careful consideration of
S&W Australia's financial position and ongoing challenges in
the current market environment. These challenges include the lack
of viable strategic alternatives to Saudi
Arabia's recent discontinuation of import permits for
alfalfa seed and all forages, and the increased risk that S&W
Australia would be unable to meet its debt obligations. VA is a
process designed to assess a company's financial situation and
operations and explore options to provide a better return for
creditors. The VA process is expected to conclude in the fourth
quarter of calendar year 2024."
"As we look to the remainder of fiscal 2025, we are laser
focused on the continued growth and expansion of our Double Team
operations in the Americas, while working toward resolve the VA
process involving a significant portion of our international
operations. We intend to provide a detailed outlook for our go
forward operations as part of the release of our first quarter
fiscal 2025 financial results in mid-November 2024," Herrmann concluded.
Financial Results
Total revenue for fiscal 2024 was $60.4
million compared to total revenue for fiscal 2023 of
$73.5 million. The $13.1 million decrease in revenue was primarily
attributable to an $11.4 million
decrease in non-dormant alfalfa sales in the Middle East North
Africa, or MENA, region due to the ongoing conflict in Sudan, reduced sales into Libya, and the import restrictions enacted in
Saudi Arabia, a $2.8 million decrease in the Australian domestic
market across all crop segments due to inventory quality and lower
pricing, a $2.8 million decrease in
non-traited sorghum sales in the U.S., a $1.7 million decrease in Mexico driven by decreased non-dormant alfalfa
sales that were partially offset with increased grain sorghum
sales, and a $1.3 million decrease in
sales to Asia of alfalfa and
sunflower. This was partially offset by a $4.3 million increase in Double Team sorghum
revenue, a $1.7 million increase in
dormant alfalfa sales in the U.S., and a $1.0 million increase in grain sorghum to
South Africa.
Gross profit margin for fiscal 2024 was 26.2% compared to gross
profit margin for fiscal 2023 of 19.8%. The improvement in gross
profit margin was primarily driven by increased sales of higher
margin Double Team sorghum and decreased sales of low margin
sorghum forages and grasses. The 6.4 percentage point increase is
attributed to increased sales of higher margin products including
Double Team sorghum (6.3 percentage points) and improved focus on
inventory management and reducing operational costs while
increasing efficiencies in S&W's production facilities (3.9
percentage points), offset by decreased margin of non-dormant
alfalfa driven by reduced demand in the MENA region (-3.4
percentage points) and lower volumes in the Australian domestic
market (-0.4 percentage points).
GAAP operating expenses for fiscal 2024 were $33.5 million compared to GAAP operating expenses
for fiscal 2023 of $32.5 million.
This increase was primarily driven by a $3.5
million increase attributable to impairment charges related
to intangibles offset by a $1.2
million decrease in research and development expenses, a
$0.7 million decrease in selling,
general and administrative expenses, a $0.5
million decrease in depreciation and amortization, and a
$0.2 million decrease in (gain) loss
on disposal of property, plant and equipment.
Adjusted operating expenses (see Table A1) for fiscal 2024 were
$25.1 million compared to
$26.4 million for fiscal 2023. The
$1.3 million decrease in adjusted
operating expenses for fiscal 2024 was attributed to a $1.2 million decrease in research and development
expenses and a $0.1 million decrease
in selling, general, and administrative expenses after excluding
non-recurring transaction costs.
GAAP net loss for fiscal 2024 was ($30.1)
million, or ($13.21) per basic
and diluted share, compared to GAAP net income of $14.4 million, or $6.40 per basic share and $6.38 per diluted share, for fiscal 2023.
Adjusted net loss (see Table A2) for fiscal 2024 was
($21.3) million, or ($9.35) per basic and diluted share, excluding
impairment charges, interest expense - amortization of debt
discount, non-recurring transaction costs, dividends accrued for
participating securities and accretion, loss on sale of equity
investment, and equity in loss of equity method investee (Vision
Bioenergy), net of tax. Adjusted net loss (see Table A2) for fiscal
2023 was ($20.3) million, or
($9.02) per basic share and
($8.98) per diluted share, excluding
interest expense - amortization of debt discount, other finance
expenses, non-recurring transaction costs, dividends accrued for
participating securities and accretion, gain on sale of business
interest, gain on sale of equity investment, and equity in loss of
equity method investee (Vision Bioenergy), net of tax.
Adjusted EBITDA (see Table B) for fiscal 2024 was
($8.5) million compared to adjusted
EBITDA for fiscal 2023 of ($9.3)
million.
S&W Australia
S&W Australia's entry into VA constitutes an event of
default and automatic acceleration of S&W Australia's
obligations under its debt facilities with National Australia Bank,
or NAB. However, such acceleration is stayed, or paused, while
S&W Australia is under VA. The NAB debt facilities are
guaranteed by S&W Seed Company, or S&W, up to a maximum of
AUD $15.0 million (USD $10.0 million as of June
30, 2024). S&W's obligations under this guarantee are
not subject to a stay in connection with S&W Australia's VA.
S&W is working with the administrators of the VA and NAB on a
resolution to the VA process. S&W Australia's entry into VA
also constituted an event of default under S&W's Amended and
Restated Loan and Security Agreement with CIBC Bank USA, or CIBC, because of a cross-default
provision in S&W's loan agreement with CIBC that is triggered
by the event of default under NAB's debt facilities. S&W
obtained a waiver from CIBC on the cross-default event on
July 31, 2024 and communicates
frequently with CIBC on the progress of S&W's activities with
the administrators of the VA and NAB throughout the VA process.
Nasdaq Listing
As previously announced, S&W received a letter from The
Nasdaq Stock Market on November 14,
2023 advising S&W that for 30 consecutive trading days
preceding the date of the notice, the bid price of S&W's common
stock had closed below the $1.00 per
share minimum required for continued listing on The Nasdaq Capital
Market pursuant to Nasdaq Listing Rule 5550(a)(2), or the Rule.
S&W subsequently requested an extension of time to regain
compliance with the Rule and submitted to Nasdaq a plan to regain
compliance. On May 14, 2024, Nasdaq
informed S&W that the request for extension was granted. As a
result of the extension, S&W must provide evidence that it has
regained compliance with the Rule by November 11, 2024.
Following a special meeting of stockholders, S&W's Board of
Directors, or the Board, unanimously approved a reverse stock split
of all issued and outstanding shares of the Company's common stock,
at a ratio of 1-for-19, or the Reverse Stock Split. The Reverse
Stock Split was implemented at 5:00 p.m.
Eastern Time on October 17,
2024. The Company's common stock began trading on a
split-adjusted basis commencing upon market opening on The Nasdaq
Capital Market on October 18,
2024.
Fiscal 2025 Guidance
S&W anticipates providing a detailed financial outlook for
fiscal 2025 in its first quarter fiscal 2025 financial results
press release and related earnings call in mid-November 2024.
Conference Call
S&W has scheduled a conference call for Friday, November 1, 2024, at 11:00am ET (8:00am
PT) to review these results. Interested parties can access
the conference call by dialing (844) 861-5498 or (412) 317-6580 or
can listen via a live Internet webcast, which is available in the
Investor Relations section of S&W's website at
http://www.swseedco.com/investors or
https://app.webinar.net/E4zbZn8e7B9. A teleconference replay of the
call will be available for seven days at (877) 344-7529 or (412)
317-0088, confirmation #9057007. A webcast replay will be available
in the Investor Relations section of S&W's website at
http://www.swseedco.com/investors or
https://app.webinar.net/E4zbZn8e7B9 for 30 days.
Non-GAAP Financial Measures
In addition to financial results reported in accordance with
accounting principles generally accepted in the United States of America ("GAAP"), S&W
has provided the following non-GAAP financial measures in this
release and the accompanying tables: adjusted EBITDA; adjusted
operating expenses; as well as adjusted net loss and adjusted net
loss per share. S&W uses these non-GAAP financial measures
internally to facilitate period-to-period comparisons and analysis
of its operating performance and liquidity, and believes they are
useful to investors as a supplement to GAAP measures in analyzing,
trending and benchmarking the performance and value of its
business. However, these measures are not intended to be a
substitute for those reported in accordance with GAAP. These
measures may be different from non-GAAP financial measures used by
other companies, even when similar terms are used to identify such
measures.
For reconciliations of historical non-GAAP financial measures to
the most comparable financial measures under GAAP, see Tables A1,
A2, and B accompanying this release.
In order to calculate these non-GAAP financial measures, S&W
makes targeted adjustments to certain GAAP financial line items
found on its condensed consolidated statement of operations,
backing out non-recurring or unique items that we believe otherwise
distort the underlying results and trends of the ongoing business.
S&W has excluded the following items from one or more of its
non-GAAP financial measures for the periods presented:
Selling, general and administrative expenses; operating
expenses. S&W excludes from operating expenses depreciation
and amortization and a portion of SG&A expense related to
non-recurring transaction costs and, for its adjusted EBITDA
calculation, also non-cash stock-based compensation. S&W
excludes non-recurring transaction costs from S&W's total
operating expenses to provide investors a method to compare its
operating results to prior periods and to peer companies, as such
amounts can vary significantly based on the frequency of
restructuring or acquisition events and the magnitude of
restructuring or acquisition expenses.
Gain on disposal of intangible assets. The gain is the
result of S&W's transfer of certain intellectual property
rights under a license agreement to Trigall Australia as part of
its equity investment in the partnership in fiscal 2023. This is a
unique item unrelated to its core performance during any particular
period. S&W believes it is useful to exclude these amounts in
order to better understand its business performance and allow
investors to compare its results with peer companies.
Impairment charges. The intangibles impairment charge
relates to the impairment of the customer relationships intangible
in Australia that resulted from
its long-lived assets impairment testing. This amount was a
non-cash charge and is unrelated to S&W's core performance
during any particular period. S&W believes it is useful to
exclude these amounts in order to better understand its business
performance and allow investors to compare its results with peer
companies.
Foreign currency loss. The foreign currency loss
represents fluctuations from changes in exchange rates that are
uncertain or out of S&W's control and cannot be reasonably
predicted. S&W believes it is useful to exclude this amount in
order to better understand its business performance and allow
investors to compare its results with peer companies.
Interest expense – amortization of debt discount.
Amortization of debt discount and debt issuance costs are primarily
related to S&W's working capital lines of credit and term
loans. These amounts are non-cash charges and are unrelated to its
core performance during any particular period. S&W believes it
is useful to exclude these amounts in order to better understand
its business performance and allow investors to compare its results
with peer companies.
Interest expense, net. Interest expense, net primary
consists of interest incurred on S&W's working capital credit
facilities, the MFP Loan, the AgAmerica loan, and equipment capital
leases. S&W believes it is useful to exclude these amounts in
order to better understand its business performance and allow
investors to compare its results with peer companies.
Dividends accrued for participating securities and
accretion. Dividends accrued for participating securities and
accretion relates to dividends accrued for the Series B convertible
preferred stock and the accretion for the discount related to the
warrants issued in conjunction with the Series B convertible
preferred stock. S&W believes it is useful to exclude these
amounts in order to better understand its business performance and
allow investors to compare its results with peer companies.
Loss (gain) on sale of business interest. The loss (gain)
on the sale of business interest relates to the (loss) gain S&W
recognized from the Vision Bioenergy transaction, for which we have
a 34% membership interest. S&W believes it is useful to exclude
these amounts in order to better understand its business
performance and allow investors to compare its results with peer
companies.
Loss (gain) on sale of equity investment. The loss (gain)
on the sale of equity investment represents the sale of S&W's
remaining 20% interest in Trigall Australia and the sale from
S&W's Bioceres investment. S&W believes it is useful to
exclude these amounts in order to better understand its business
performance and allow investors to compare its results with peer
companies.
Equity in loss of equity method investee (Vision Bioenergy), net
of tax. This loss represents S&W's percentage of Vision
Bioenergy's loss for the years ended June
30, 2024 and 2023, as it has significant influence in Vision
Bioenergy. S&W believes it is useful to exclude these amounts
in order to better understand its business performance and allow
investors to compare its results with peer companies.
Descriptions of the non-GAAP financial measures included in this
release and the accompanying tables are as follows:
Adjusted Operating Expenses. S&W defines adjusted
operating expenses as GAAP operating expenses adjusted to exclude
depreciation and amortization, loss on disposal of property, plant
and equipment, non-recurring transaction costs, and impairment
charges. S&W believes that the use of adjusted operating
expenses is useful to investors and other users of its financial
statements in evaluating its operating performance because it
provides a method to compare its operating results to prior periods
and to peer companies after making adjustments for depreciation and
amortization and amounts that are not expected to recur.
Adjusted net loss and loss per share. S&W defines
adjusted net loss as net (loss) income attributable to S&W less
interest expense – amortization of debt discount, non-recurring
transaction costs, impairment charges, dividends accrued for
participating securities and accretion, gain on sale of business
interest, loss (gain) on sale of equity investment, and equity in
loss of equity method investee (Vision Bioenergy), net of tax.
S&W believes that these non-GAAP financial measures provide
useful supplemental information for evaluating its operating
performance.
Adjusted EBITDA. S&W defines adjusted EBITDA as net
(loss) income attributable to S&W adjusted to exclude interest
expense, net, interest expense – amortization of debt discount,
benefit from income taxes, depreciation and amortization,
non-recurring transaction costs, impairment charges, non-cash
stock-based compensation, foreign currency loss, gain on sale of
business interest, loss (gain) on sale of equity investment, gain
on disposal of intangible assets, equity in loss of equity method
investee (Vision Bioenergy), net of tax, and dividends accrued for
participating securities and accretion. S&W believes that the
use of adjusted EBITDA is useful to investors and other users of
its financial statements in evaluating its operating performance
because it provides them with an additional tool to compare
business performance across companies and across periods. S&W
uses adjusted EBITDA in conjunction with traditional GAAP operating
performance measures as part of its overall assessment of its
performance, for planning purposes, including the preparation of
its annual operating budget, to evaluate the effectiveness of its
business strategies and to communicate with its Board concerning
its financial performance. Management does not place undue reliance
on adjusted EBITDA as its only measure of operating performance.
Adjusted EBITDA should not be considered as a substitute for other
measures of financial performance reported in accordance with
GAAP.
Financial Tables
For a complete press release including financial tables, please
view online at: https://swseedco.com/investors/press-releases/.
About S&W Seed Company
Founded in 1980, S&W is a global multi-crop, middle-market
agricultural company headquartered in Longmont, Colorado. S&W's vision is to be
the world's preferred proprietary seed company which supplies a
range of sorghum, forage and specialty crop products that supports
the growing global demand for animal proteins and healthier
consumer diets. S&W is a global leader in proprietary alfalfa
and sorghum seeds with significant research and development,
production and distribution capabilities. S&W also has a
commercial presence in pasture and sunflower seeds, and through a
partnership, is focused on sustainable biofuel feedstocks primarily
within camelina. For more information, please visit
www.swseedco.com.
Safe Harbor Statement
This release contains "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended
and such forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. "Forward-looking statements" describe future expectations,
plans, results, or strategies and are generally preceded by words
such as "ability," "believe," "may," "future," "plan," "intends"
"should" or "expects." Forward-looking statements in this release
include, but are not limited to: the timing of the resolution of
the VA; our success in growing and expanding our Double Team
operations in the Americas; our expected timelines for the
development and launch of our products; the continued rapid
adoption of Double Team Grain Sorghum and projected growth of its
share of all grain sorghum acres in the U.S.; the shift in revenue
towards our higher margin products; and the success of our
cost-saving, production optimization and operational initiatives to
mitigate the impact of geopolitical events and drive our business
towards profitability. You are cautioned that such statements are
subject to a multitude of risks and uncertainties that could cause
future circumstances, events, or results to differ materially from
those projected in the forward-looking statements, including risks
and uncertainties related to: market adoption of
products designed to support the energy transition and customer
demand for our partnership's products; the effects of unexpected
weather and geopolitical and macroeconomic events, such as global
inflation, bank failures, supply chain disruptions, uncertain
market conditions, the armed conflict in Sudan, the import ban on alfalfa seed in
Saudi Arabia, the ongoing military
conflict between Russia and
Ukraine and related sanctions and
the conflict in the Middle East,
on our business and operations as well as those of our partnership,
and the extent to which they disrupt the local and global
economies, as well as our business and the businesses of our
partnership, our customers, distributors and suppliers; sufficiency
of our partnership's cash and access to capital in order to develop
its business; the sufficiency of our cash and access to capital in
order to meet our liquidity needs, including our ability to pay our
growers as our payment obligations come due and to meet any
obligations resulting from the VA and our guarantee of S&W
Australia's obligations under the NAB debt facility; our need to
comply with the financial covenants included in our loan
agreements, refinance certain of our credit facilities and raise
additional capital in the future and our ability to continue as a
"going concern"; changes in market conditions, including any
unexpected decline in commodity prices, may harm our results of
operations and revenue outlook; our proprietary seed trait
technology products, including Double Team, may not yield their
anticipated benefits, including with respect to their impact on
revenues and gross margins; changes in the competitive
landscape and the introduction of competitive products may
negatively impact our results of operations; demand for our Double
Team sorghum solution may not be as strong as expected; our
business strategic initiatives may not achieve the expected
results; previously experienced logistical challenges in shipping
and transportation of our products may become amplified, delaying
our ability to recognize revenue and decreasing our gross margins;
we may be unable to achieve our goals to drive growth, improve
gross margins and reduce operating expenses; the inherent
uncertainty and significant judgments and assumptions underlying
our financial guidance; and the risks associated with our ability
to successfully optimize and commercialize our business. These and
other risks are identified in our filings with the Securities and
Exchange Commission, including, without limitation, our Annual
Report on Form 10-K for the year ended June
30, 2024 and in other filings subsequently made by us with
the Securities and Exchange Commission. All forward-looking
statements contained in this press release speak only as of the
date on which they were made and are based on management's
assumptions and estimates as of such date. We do not undertake any
obligation to publicly update any forward-looking statements,
whether as a result of the receipt of new information, the
occurrence of future events or otherwise.
Company Contact:
Mark Herrmann, Chief Executive
Officer
S&W Seed Company
Phone: (720) 593-3570
www.swseedco.com
Investor Contact:
Robert Blum
Lytham Partners, LLC
Phone: (602) 889-9700
sanw@lythampartners.com
www.lythampartners.com
S & W SEED
COMPANY
|
CONSOLIDATED
STATEMENTS OF OPERATIONS
|
(UNAUDITED)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months
Ended
|
|
|
|
Years
Ended
|
|
|
June
30,
|
|
|
|
June
30,
|
|
|
2024
|
|
|
2023
|
|
|
|
2024
|
|
|
2023
|
Revenue
|
|
$
|
14,819,736
|
|
|
$
|
23,055,316
|
|
|
|
$
|
60,441,646
|
|
|
$
|
73,521,291
|
Cost of revenue
(excluding depreciation and amortization)
|
|
|
12,339,724
|
|
|
|
20,193,918
|
|
|
|
|
44,631,897
|
|
|
|
58,983,210
|
Gross profit
|
|
|
2,480,012
|
|
|
|
2,861,398
|
|
|
|
|
15,809,749
|
|
|
|
14,538,081
|
Operating
expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and
administrative expenses
|
|
|
4,410,084
|
|
|
|
5,144,445
|
|
|
|
|
21,725,874
|
|
|
|
22,430,687
|
Research and
development expenses
|
|
|
1,044,892
|
|
|
|
1,014,394
|
|
|
|
|
4,062,419
|
|
|
|
5,237,772
|
Depreciation and
amortization
|
|
|
1,067,176
|
|
|
|
1,071,265
|
|
|
|
|
4,288,449
|
|
|
|
4,768,809
|
(Gain) loss on
disposal of property, plant and equipment
|
|
|
(19,121)
|
|
|
|
11,423
|
|
|
|
|
(109,746)
|
|
|
|
44,335
|
Impairment
charges
|
|
|
3,531,010
|
|
|
|
—
|
|
|
|
|
3,531,010
|
|
|
|
—
|
Total operating
expenses
|
|
|
10,034,041
|
|
|
|
7,241,527
|
|
|
|
|
33,498,006
|
|
|
|
32,481,603
|
Loss from
operations
|
|
|
(7,554,029)
|
|
|
|
(4,380,129)
|
|
|
|
|
(17,688,257)
|
|
|
|
(17,943,522)
|
Other (income)
expense
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency
loss
|
|
|
50,165
|
|
|
|
162,189
|
|
|
|
|
1,213,732
|
|
|
|
859,696
|
Government grant
income
|
|
|
—
|
|
|
|
—
|
|
|
|
|
—
|
|
|
|
(1,444,044)
|
Loss (gain) on sale of
business interest
|
|
|
—
|
|
|
|
156,404
|
|
|
|
|
—
|
|
|
|
(38,167,102)
|
Gain on disposal of
intangible assets
|
|
|
—
|
|
|
|
—
|
|
|
|
|
—
|
|
|
|
(1,796,252)
|
Loss (gain) on sale of
equity investment
|
|
|
534,189
|
|
|
|
—
|
|
|
|
|
534,189
|
|
|
|
(32,030)
|
Interest expense -
amortization of debt discount
|
|
|
515,953
|
|
|
|
416,339
|
|
|
|
|
1,883,573
|
|
|
|
1,975,938
|
Interest expense,
net
|
|
|
1,380,668
|
|
|
|
1,142,483
|
|
|
|
|
5,520,991
|
|
|
|
4,184,067
|
Other (income)
expenses
|
|
|
8,301
|
|
|
|
56,098
|
|
|
|
|
(139,067)
|
|
|
|
1,552,154
|
(Loss) income before
income taxes
|
|
|
(10,043,305)
|
|
|
|
(6,313,642)
|
|
|
|
|
(26,701,675)
|
|
|
|
14,924,051
|
Provision for (benefit
from) income taxes
|
|
|
1,350,884
|
|
|
|
115,150
|
|
|
|
|
496,290
|
|
|
|
(763,639)
|
(Loss) income before
equity in net earnings of affiliates
|
|
|
(11,394,189)
|
|
|
|
(6,428,792)
|
|
|
|
|
(27,197,965)
|
|
|
|
15,687,690
|
Equity in loss of
equity method investees, net of tax
|
|
|
733,748
|
|
|
|
841,637
|
|
|
|
|
2,858,424
|
|
|
|
1,252,330
|
Net (loss)
income
|
|
|
(12,127,937)
|
|
|
|
(7,270,429)
|
|
|
|
|
(30,056,389)
|
|
|
|
14,435,360
|
(Loss) income
attributable to noncontrolling interests
|
|
|
(15,981)
|
|
|
|
41,924
|
|
|
|
|
(25,412)
|
|
|
|
25,282
|
Net (loss) income
attributable to S&W Seed Company
|
|
$
|
(12,111,956)
|
|
|
$
|
(7,312,353)
|
|
|
|
$
|
(30,030,977)
|
|
|
$
|
14,410,078
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Calculation of net
(loss) income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income
attributable to S&W Seed Company
|
|
$
|
(12,111,956)
|
|
|
$
|
(7,312,353)
|
|
|
|
$
|
(30,030,977)
|
|
|
$
|
14,410,078
|
Dividends accrued for
participating securities and accretion
|
|
|
(126,782)
|
|
|
|
(120,070)
|
|
|
|
|
(494,617)
|
|
|
|
(469,329)
|
Net (loss) income
attributable to common shareholders
|
|
$
|
(12,238,738)
|
|
|
$
|
(7,432,423)
|
|
|
|
$
|
(30,525,594)
|
|
|
$
|
13,940,749
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income
attributable to S&W Seed Company per common
share,
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
(5.31)
|
|
|
$
|
(3.23)
|
|
|
|
$
|
(13.21)
|
|
|
$
|
6.40
|
Diluted
|
|
$
|
(5.31)
|
|
|
$
|
(3.22)
|
|
|
|
$
|
(13.21)
|
|
|
$
|
6.38
|
Weighted average number
of common shares outstanding,
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
2,281,258
|
|
|
|
2,261,486
|
|
|
|
|
2,273,112
|
|
|
|
2,250,146
|
Diluted
|
|
|
2,281,258
|
|
|
|
2,269,553
|
|
|
|
|
2,273,112
|
|
|
|
2,259,766
|
TABLE
A1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
S&W SEED
COMPANY
|
ITEMIZED
RECONCILIATION BETWEEN OPERATING EXPENSES AND NON-GAAP ADJUSTED
OPERATING EXPENSES
|
(UNAUDITED)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months
Ended
June 30,
|
|
|
Years Ended
June 30,
|
|
|
|
|
2024
|
|
|
2023
|
|
|
2024
|
|
|
2023
|
|
|
Operating
expenses
|
|
|
10,034,041
|
|
|
|
7,241,527
|
|
|
|
33,498,006
|
|
|
|
32,481,603
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
(1,067,176)
|
|
|
|
(1,071,265)
|
|
|
|
(4,288,449)
|
|
|
|
(4,768,809)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-recurring transaction costs
|
|
|
(150,447)
|
|
|
|
(274,434)
|
|
|
|
(713,526)
|
|
|
|
(1,240,274)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain
(loss) on disposal of property, plant and equipment
|
|
|
19,121
|
|
|
|
(11,423)
|
|
|
|
109,746
|
|
|
|
(44,335)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impairment charges
|
|
|
(3,531,010)
|
|
|
|
-
|
|
|
|
(3,531,010)
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP adjusted
operating expenses
|
|
|
5,304,529
|
|
|
|
5,884,405
|
|
|
|
25,074,767
|
|
|
|
26,428,185
|
|
|
TABLE
A2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
S&W SEED
COMPANY
|
ITEMIZED
RECONCILIATION BETWEEN NET LOSS AND NON-GAAP ADJUSTED NET
LOSS
|
(UNAUDITED)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months
Ended
June 30,
|
|
|
Years Ended
June 30,
|
|
|
|
|
2024
|
|
|
2023
|
|
|
2024
|
|
|
2023
|
|
|
Net (loss) income
attributable to S&W Seed Company
|
|
$
|
(12,111,956)
|
|
|
$
|
(7,312,353)
|
|
|
$
|
(30,030,977)
|
|
|
$
|
14,410,078
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impairment
charges
|
|
|
3,531,010
|
|
|
|
—
|
|
|
|
3,531,010
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense -
amortization of debt discount
|
|
|
515,953
|
|
|
|
416,339
|
|
|
|
1,883,573
|
|
|
|
1,975,938
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other finance
expenses
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
1,458,168
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain on disposal of
intangible assets
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(1,796,252)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-recurring
transaction costs
|
|
|
150,447
|
|
|
|
274,434
|
|
|
|
713,526
|
|
|
|
1,240,274
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends accrued for
participating securities and accretion
|
|
|
(126,782)
|
|
|
|
(120,070)
|
|
|
|
(494,617)
|
|
|
|
(469,329)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss (gain) on sale of
business interest
|
|
|
—
|
|
|
|
156,404
|
|
|
|
—
|
|
|
|
(38,167,102)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss (gain) on sale of
equity investment
|
|
|
534,189
|
|
|
|
—
|
|
|
|
534,189
|
|
|
|
(32,030)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity in loss of
equity method investee (Vision
Bioenergy), net of tax
|
|
|
771,647
|
|
|
|
323,538
|
|
|
|
2,613,277
|
|
|
|
1,089,346
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP adjusted net
loss
|
|
$
|
(6,735,492)
|
|
|
$
|
(6,261,708)
|
|
|
$
|
(21,250,019)
|
|
|
$
|
(20,290,909)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP adjusted net
loss attributable to
S&W Seed Company per common
share,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
(2.95)
|
|
|
$
|
(2.77)
|
|
|
$
|
(9.35)
|
|
|
$
|
(9.02)
|
|
|
Diluted
|
|
$
|
(2.95)
|
|
|
$
|
(2.76)
|
|
|
$
|
(9.35)
|
|
|
$
|
(8.98)
|
|
|
Weighted average number
of common shares outstanding,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
2,281,258
|
|
|
|
2,261,486
|
|
|
|
2,273,112
|
|
|
|
2,250,146
|
|
|
Diluted
|
|
|
2,281,258
|
|
|
|
2,269,553
|
|
|
|
2,273,112
|
|
|
|
2,259,766
|
|
|
TABLE
B
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
S&W SEED
COMPANY
|
|
|
ITEMIZED
RECONCILIATION BETWEEN NET LOSS AND NON-GAAP ADJUSTED
EBITDA
|
|
|
(UNAUDITED)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months
Ended
|
|
Years
Ended
|
|
|
|
|
|
June
30,
|
|
June
30,
|
|
|
|
|
|
2024
|
|
|
|
2023
|
|
|
|
2024
|
|
|
|
2023
|
|
|
Net (loss) income
attributable to S&W Seed Company
|
|
$
|
|
(12,111,956)
|
|
|
$
|
|
(7,312,353)
|
|
|
$
|
|
(30,030,977)
|
|
|
$
|
|
14,410,078
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense,
net
|
|
|
|
1,380,668
|
|
|
|
|
1,142,483
|
|
|
|
|
5,520,991
|
|
|
|
|
4,184,067
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense -
amortization of debt discount
|
|
|
|
515,953
|
|
|
|
|
416,339
|
|
|
|
|
1,883,573
|
|
|
|
|
1,975,938
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other finance
expenses
|
|
|
|
—
|
|
|
|
|
—
|
|
|
|
|
—
|
|
|
|
|
1,458,168
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for (benefit
from) income taxes
|
|
|
|
1,350,884
|
|
|
|
|
115,150
|
|
|
|
|
496,290
|
|
|
|
|
(763,639)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and
amortization
|
|
|
|
1,067,176
|
|
|
|
|
1,071,265
|
|
|
|
|
4,288,449
|
|
|
|
|
4,768,809
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impairment
charges
|
|
|
|
3,531,010
|
|
|
|
|
—
|
|
|
|
|
3,531,010
|
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-recurring
transaction costs
|
|
|
|
150,447
|
|
|
|
|
274,434
|
|
|
|
|
713,526
|
|
|
|
|
1,240,274
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-cash stock-based
compensation
|
|
|
|
253,708
|
|
|
|
|
549,522
|
|
|
|
|
1,232,938
|
|
|
|
|
1,932,415
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency
loss
|
|
|
|
50,165
|
|
|
|
|
162,189
|
|
|
|
|
1,213,732
|
|
|
|
|
859,696
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain on disposal of
intangible assets
|
|
|
|
—
|
|
|
|
|
—
|
|
|
|
|
—
|
|
|
|
|
(1,796,252)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss (gain) on sale of
business
|
|
|
|
—
|
|
|
|
|
156,404
|
|
|
|
|
—
|
|
|
|
|
(38,167,102)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss (gain) on sale of
equity investments
|
|
|
|
534,189
|
|
|
|
|
—
|
|
|
|
|
534,189
|
|
|
|
|
(32,030)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity in loss of
equity method investee (Vision
Bioenergy), net of tax
|
|
|
|
771,647
|
|
|
|
|
765,808
|
|
|
|
|
2,613,277
|
|
|
|
|
1,089,346
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends accrued for
participating securities and
accretion
|
|
|
|
(126,782)
|
|
|
|
|
(120,070)
|
|
|
|
|
(494,617)
|
|
|
|
|
(469,329)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP adjusted
EBITDA
|
|
$
|
|
(2,632,891)
|
|
|
$
|
|
(2,778,829)
|
|
|
$
|
|
(8,497,619)
|
|
|
$
|
|
(9,309,561)
|
|
|
S & W SEED
COMPANY
|
|
CONSOLIDATED BALANCE
SHEETS
|
|
(UNAUDITED)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of
June 30, 2024
|
|
|
|
As of
June 30, 2023
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
CURRENT
ASSETS
|
|
|
|
|
|
|
|
|
|
Cash and cash
equivalents
|
|
|
$
|
|
294,014
|
|
|
$
|
|
3,398,793
|
|
Accounts receivable,
net
|
|
|
|
|
20,865,224
|
|
|
|
|
24,622,727
|
|
Notes receivable,
net
|
|
|
|
|
—
|
|
|
|
|
6,846,897
|
|
Inventories,
net
|
|
|
|
|
38,107,103
|
|
|
|
|
45,098,268
|
|
Prepaid expenses and
other current assets
|
|
|
|
|
4,108,149
|
|
|
|
|
4,099,027
|
|
TOTAL CURRENT
ASSETS
|
|
|
|
|
63,374,490
|
|
|
|
|
84,065,712
|
|
Property, plant and
equipment, net
|
|
|
|
|
9,667,273
|
|
|
|
|
10,082,168
|
|
Intellectual property,
net
|
|
|
|
|
20,265,618
|
|
|
|
|
21,650,534
|
|
Other Intangibles,
net
|
|
|
|
|
3,783,389
|
|
|
|
|
8,082,325
|
|
Right of use asset -
operating leases
|
|
|
|
|
2,248,818
|
|
|
|
|
2,983,303
|
|
Equity method
investments
|
|
|
|
|
19,694,209
|
|
|
|
|
23,059,705
|
|
Other assets
|
|
|
|
|
1,691,744
|
|
|
|
|
2,066,081
|
|
TOTAL
ASSETS
|
|
|
$
|
|
120,725,541
|
|
|
$
|
|
151,989,828
|
|
LIABILITIES,
MEZZANINE EQUITY AND STOCKHOLDERS'
EQUITY
|
|
|
|
|
|
|
|
|
|
CURRENT
LIABILITIES
|
|
|
|
|
|
|
|
|
|
Accounts
payable
|
|
|
$
|
|
13,491,826
|
|
|
$
|
|
13,312,180
|
|
Deferred
revenue
|
|
|
|
|
872,739
|
|
|
|
|
464,707
|
|
Accrued expenses and
other current liabilities
|
|
|
|
|
6,894,494
|
|
|
|
|
8,804,456
|
|
Current portion of
working capital lines of credit, net
|
|
|
|
|
43,724,157
|
|
|
|
|
44,900,779
|
|
Current portion of
long-term debt, net
|
|
|
|
|
4,259,108
|
|
|
|
|
3,808,761
|
|
TOTAL CURRENT
LIABILITIES
|
|
|
|
|
69,242,324
|
|
|
|
|
71,290,883
|
|
Long-term debt, net,
less current portion
|
|
|
|
|
4,873,236
|
|
|
|
|
4,499,334
|
|
Other non-current
liabilities
|
|
|
|
|
1,578,856
|
|
|
|
|
2,102,030
|
|
TOTAL
LIABILITIES
|
|
|
|
|
75,694,416
|
|
|
|
|
77,892,247
|
|
MEZZANINE
EQUITY
|
|
|
|
|
|
|
|
|
|
Preferred stock,
$0.001 par value; 3,323 shares authorized; 1,695 issued
and outstanding at June 30, 2024 and June 30, 2023
|
|
|
|
|
5,768,765
|
|
|
|
|
5,274,148
|
|
TOTAL MEZZANINE
EQUITY
|
|
|
|
|
5,768,765
|
|
|
|
|
5,274,148
|
|
STOCKHOLDERS'
EQUITY
|
|
|
|
|
|
|
|
|
|
Common stock, $0.001
par value; 75,000,000 shares authorized;
2,282,574 issued and 2,281,258 outstanding at June 30, 2024;
2,263,369
issued and 2,262,054 outstanding at June 30, 2023
|
|
|
|
|
43,369
|
|
|
|
|
43,004
|
|
Treasury stock, at
cost, 1,316 shares at June 30, 2024 and June 30, 2023
|
|
|
|
|
(134,196)
|
|
|
|
|
(134,196)
|
|
Additional paid-in
capital
|
|
|
|
|
168,807,072
|
|
|
|
|
167,768,104
|
|
Accumulated
deficit
|
|
|
|
|
(122,090,479)
|
|
|
|
|
(91,932,808)
|
|
Accumulated other
comprehensive loss
|
|
|
|
|
(7,405,114)
|
|
|
|
|
(6,987,791)
|
|
Noncontrolling
interests
|
|
|
|
|
41,708
|
|
|
|
|
67,120
|
|
TOTAL STOCKHOLDERS'
EQUITY
|
|
|
|
|
39,262,360
|
|
|
|
|
68,823,433
|
|
TOTAL LIABILITIES,
MEZZANINE EQUITY AND
STOCKHOLDERS' EQUITY
|
|
|
$
|
|
120,725,541
|
|
|
$
|
|
151,989,828
|
|
S & W SEED
COMPANY
|
CONSOLIDATED
STATEMENTS OF CASH FLOWS
|
(UNAUDITED)
|
|
|
|
Years Ended June
30,
|
|
|
|
2024
|
|
|
|
2023
|
CASH FLOWS FROM
OPERATING ACTIVITIES
|
|
|
|
|
|
|
|
Net (loss)
income
|
|
$
|
|
(30,056,389)
|
|
|
$
|
|
14,435,360
|
Adjustments to
reconcile net (loss) income from operating activities to net cash
used in
operating activities:
|
|
|
|
|
|
|
|
Stock-based
compensation
|
|
|
|
1,232,938
|
|
|
|
|
1,932,416
|
Provision for credit
losses
|
|
|
|
462,874
|
|
|
|
|
11,659
|
Inventory
write-down
|
|
|
|
1,964,632
|
|
|
|
|
2,778,414
|
Depreciation and
amortization
|
|
|
|
4,288,450
|
|
|
|
|
4,768,809
|
Impairment
charges
|
|
|
|
3,531,010
|
|
|
|
|
—
|
(Gain) loss on
disposal of property, plant and equipment
|
|
|
|
(109,746)
|
|
|
|
|
44,335
|
Gain on disposal of
intangible assets
|
|
|
|
—
|
|
|
|
|
(1,796,252)
|
Gain on sale of equity
investment
|
|
|
|
—
|
|
|
|
|
(38,167,102)
|
Loss (gain) on sale of
equity investment
|
|
|
|
534,189
|
|
|
|
|
(32,030)
|
Equity in loss of
equity method investees, net of tax
|
|
|
|
2,858,424
|
|
|
|
|
1,252,330
|
Government grant
income
|
|
|
|
—
|
|
|
|
|
(1,444,044)
|
Change in deferred tax
provision
|
|
|
|
485,630
|
|
|
|
|
(806,479)
|
Change in foreign
exchange contracts
|
|
|
|
(823,834)
|
|
|
|
|
(63,889)
|
Foreign currency
transactions
|
|
|
|
1,212,816
|
|
|
|
|
46,283
|
Amortization of debt
discount
|
|
|
|
1,883,573
|
|
|
|
|
1,975,938
|
Accretion of note
receivable
|
|
|
|
(153,110)
|
|
|
|
|
(99,763)
|
Changes in:
|
|
|
|
|
|
|
|
Accounts
receivable
|
|
|
|
3,341,360
|
|
|
|
|
(5,840,310)
|
Inventories
|
|
|
|
5,132,472
|
|
|
|
|
5,755,856
|
Prepaid expenses and
other current assets
|
|
|
|
(1,112,299)
|
|
|
|
|
84,605
|
Other non-current
assets
|
|
|
|
78,475
|
|
|
|
|
(27,950)
|
Accounts
payable
|
|
|
|
99,359
|
|
|
|
|
(2,151,619)
|
Deferred
revenue
|
|
|
|
401,859
|
|
|
|
|
(139,826)
|
Accrued expenses and
other current liabilities
|
|
|
|
(842,663)
|
|
|
|
|
(1,344,945)
|
Other non-current
liabilities
|
|
|
|
(47,042)
|
|
|
|
|
(149,946)
|
Net cash used in
operating activities
|
|
|
|
(5,637,022)
|
|
|
|
|
(18,978,150)
|
CASH FLOWS FROM
INVESTING ACTIVITIES
|
|
|
|
|
|
|
|
Proceeds from sale of
business interest
|
|
|
|
6,000,000
|
|
|
|
|
7,000,000
|
Proceeds from
partnership transaction
|
|
|
|
1,000,000
|
|
|
|
|
2,000,000
|
Additions to property,
plant and equipment
|
|
|
|
(1,543,100)
|
|
|
|
|
(856,716)
|
Proceeds from disposal
of property, plant and equipment
|
|
|
|
458,878
|
|
|
|
|
1,417
|
Capital contributions
to partnerships
|
|
|
|
(147,239)
|
|
|
|
|
(172,917)
|
Net proceeds from sale
of equity investment
|
|
|
|
109,529
|
|
|
|
|
400,000
|
Net cash provided by
investing activities
|
|
|
|
5,878,068
|
|
|
|
|
8,371,784
|
CASH FLOWS FROM
FINANCING ACTIVITIES
|
|
|
|
|
|
|
|
Borrowings and
repayments on lines of credit, net
|
|
|
|
(2,658,002)
|
|
|
|
|
9,857,653
|
Borrowings of long-term
debt
|
|
|
|
1,335,029
|
|
|
|
|
4,208,460
|
Repayments of long-term
debt
|
|
|
|
(1,219,788)
|
|
|
|
|
(1,743,514)
|
Debt issuance
costs
|
|
|
|
(605,177)
|
|
|
|
|
(421,538)
|
Cash paid related to
stock issuance costs
|
|
|
|
(165,812)
|
|
|
|
|
—
|
Net proceeds from sale
of common stock
|
|
|
|
—
|
|
|
|
|
128,778
|
Issuance of common
stock for cash upon exercise of stock options
|
|
|
|
—
|
|
|
|
|
1,994
|
Taxes paid related to
net share settlements of stock-based compensation awards
|
|
|
|
(32,658)
|
|
|
|
|
(82,165)
|
Net cash (used in)
provided by financing activities
|
|
|
|
(3,346,408)
|
|
|
|
|
11,949,668
|
EFFECT OF EXCHANGE
RATE CHANGES ON CASH
|
|
|
|
583
|
|
|
|
|
(1,017)
|
NET (DECREASE)
INCREASE IN CASH & CASH EQUIVALENTS
|
|
|
|
(3,104,779)
|
|
|
|
|
1,342,285
|
CASH AND CASH
EQUIVALENTS, beginning of the period
|
|
|
|
3,398,793
|
|
|
|
|
2,056,508
|
CASH AND CASH
EQUIVALENTS, end of period
|
|
$
|
|
294,014
|
|
|
$
|
|
3,398,793
|
SUPPLEMENTAL
DISCLOSURES OF CASH FLOW INFORMATION
|
|
|
|
|
|
|
|
Cash paid during the
period for:
|
|
|
|
|
|
|
|
Interest
|
|
$
|
|
5,488,517
|
|
|
$
|
|
4,380,703
|
Income
taxes
|
|
|
|
29,846
|
|
|
|
|
130
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/sw-announces-fiscal-2024-financial-results-302293516.html
SOURCE S&W Seed Company